Correction to: Ronopterin (VAS203) in patients with moderate and severe traumatic brain injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study

Research output: Contribution to journal › Comment/debate › peer-review

Standard

Correction to : Ronopterin (VAS203) in patients with moderate and severe traumatic brain injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study. / NOSTRA Investigators.

In: Trials, Vol. 21, No. 1, 172, 12.02.2020.

Research output: Contribution to journal › Comment/debate › peer-review

Harvard

NOSTRA Investigators 2020, 'Correction to: Ronopterin (VAS203) in patients with moderate and severe traumatic brain injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study', Trials, vol. 21, no. 1, 172. https://doi.org/10.1186/s13063-020-4107-8

APA

NOSTRA Investigators (2020). Correction to: Ronopterin (VAS203) in patients with moderate and severe traumatic brain injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study. Trials, 21(1), [172]. https://doi.org/10.1186/s13063-020-4107-8

Vancouver

NOSTRA Investigators. Correction to: Ronopterin (VAS203) in patients with moderate and severe traumatic brain injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study. Trials. 2020 Feb 12;21(1). 172. https://doi.org/10.1186/s13063-020-4107-8

Author

NOSTRA Investigators. / Correction to : Ronopterin (VAS203) in patients with moderate and severe traumatic brain injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study. In: Trials. 2020 ; Vol. 21, No. 1.

Bibtex

@article{b46db94247594d87a4ed14fa1ebd7e67,
title = "Correction to: Ronopterin (VAS203) in patients with moderate and severe traumatic brain injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study",
abstract = "After publication of our article [1] the authors have notified us that one of the names has been incorrectly spelled. Original name spelling: Charlotte Fl{\"u}he Correct name spelling: Charlotte Fl{\"u}h The original article has been corrected.",
author = "{NOSTRA Investigators} and Frank Tegtmeier and Reinhard Schinzel and Ronny Beer and Diederik Bulters and Jean-Yves LeFrant and Joan Sahuquillo and Andreas Unterberg and Peter Andrews and Antonio Belli and Javier Ibanez and Alfonso Lagares and Michael Mokry and Harald Willschke and Charlotte Fl{\"u}h and Erich Schmutzhard",
year = "2020",
month = feb,
day = "12",
doi = "10.1186/s13063-020-4107-8",
language = "English",
volume = "21",
journal = "Trials",
issn = "1745-6215",
publisher = "Springer",
number = "1",

}

RIS

TY - JOUR

T1 - Correction to

T2 - Ronopterin (VAS203) in patients with moderate and severe traumatic brain injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study

AU - NOSTRA Investigators

AU - Tegtmeier, Frank

AU - Schinzel, Reinhard

AU - Beer, Ronny

AU - Bulters, Diederik

AU - LeFrant, Jean-Yves

AU - Sahuquillo, Joan

AU - Unterberg, Andreas

AU - Andrews, Peter

AU - Belli, Antonio

AU - Ibanez, Javier

AU - Lagares, Alfonso

AU - Mokry, Michael

AU - Willschke, Harald

AU - Flüh, Charlotte

AU - Schmutzhard, Erich

PY - 2020/2/12

Y1 - 2020/2/12

N2 - After publication of our article [1] the authors have notified us that one of the names has been incorrectly spelled. Original name spelling: Charlotte Flühe Correct name spelling: Charlotte Flüh The original article has been corrected.

AB - After publication of our article [1] the authors have notified us that one of the names has been incorrectly spelled. Original name spelling: Charlotte Flühe Correct name spelling: Charlotte Flüh The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85079339680&partnerID=8YFLogxK

U2 - 10.1186/s13063-020-4107-8

DO - 10.1186/s13063-020-4107-8

M3 - Comment/debate

C2 - 32051020

VL - 21

JO - Trials

JF - Trials

SN - 1745-6215

IS - 1

M1 - 172

ER -